SEC Comment Letter for CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856) (CORT) — Aug 24, 2010
CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856)
Date: Aug. 24, 2010 · CIK: 0001088856 · Accession: 0000000000-10-048619
AI Filing Summary & Sentiment
Reasoning
Letter
August 24, 2010 Joseph K. Belanoff Chief Executive Officer Corcept Therapeutics, Inc. 149 Commonwealth Drive Menlo Park, CA 94025
Re: Corcept Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2009 Filed March 26, 2010 File No. 0-50679
Dear Mr. Belanoff: We have completed our review of your f iling and do not have any further comments at this time. Sincerely,
Joel Parker A c c o u n t i n g B r a n c h C h i e f
Show Raw Text
August 24, 2010
Joseph K. Belanoff Chief Executive Officer Corcept Therapeutics, Inc. 149 Commonwealth Drive
Menlo Park, CA 94025
Re: Corcept Therapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2009
Filed March 26, 2010 File No. 0-50679
Dear Mr. Belanoff: We have completed our review of your f iling and do not have any further comments at
this time.
Sincerely,
Joel Parker
A c c o u n t i n g B r a n c h C h i e f